Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignancy after renal transplantation.

Martin Zeier1, Wolfgang Hartschuh, Manfred Wiesel

  • 1Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany. martin_zeier@med.uni-heidelberg.de

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kidney & blood pressure research·2018
Same author

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Clinical and experimental nephrology·2017
Same author

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Clinical kidney journal·2016
Same author

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

BMC nephrology·2016
Same author

Bariatric surgery and the kidney-much benefit, but also potential harm.

Clinical kidney journal·2016
Same author

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Journal of hypertension·2016
Same journal

Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

High Protein Diets: What to Tell Our Patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Progressive Kidney Dysfunction and Ocular Clues: A Quiz.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Influence of Lactate Dehydrogenase on the Measurement of Blood Bicarbonate.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Urinary CXCL9 and CXCL10, Interstitial Inflammation and Disease Activity Over Time in Acute Interstitial Nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
See all related articles

Malignancy risk is significantly higher after renal transplantation, with common types including lymphoproliferative disorders and skin cancers. Early detection and modified immunosuppression are crucial for managing post-transplant cancer.

Area of Science:

  • Nephrology
  • Oncology
  • Immunology

Background:

  • Malignancy is a significant long-term complication following renal transplantation.
  • The incidence of cancer post-transplant is 3-5 times higher than in the general population.

Observation:

  • Common malignancies include lymphoproliferative disorders (early) and skin carcinomas (late).
  • Cancer types vary globally due to genetic and environmental factors.
  • Immunosuppression regimens, cytotoxic drug history, and analgesic abuse are key risk factors.

Findings:

  • Malignancy can potentially be transmitted via the transplanted kidney graft.
  • Prior cancer treatment in uremic patients impacts transplant waiting times and screening protocols.
  • Screening before and after transplantation is vital for early tumor detection.

Related Experiment Videos

Implications:

  • Management requires tailored oncological treatment and immunosuppression modification.
  • Proactive screening programs are essential for all dialysis patients awaiting renal transplants.
  • Understanding risk factors aids in personalized post-transplant cancer surveillance.